SLNSW-Lazertinib in patients with EGFR mutation-positiv...-TN_cdi_proquest_journals_2320923108

Lazertinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: results from the dose escalation and dose expansion parts of a first-in-human, open-label, multicentre, phase 1–2 study

Full title: Lazertinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: results from the dose escalation and dose expansion parts of a first-in-human, open-label, multicentre, phase 1–2 study

Author/creator: Ahn, Myung-Ju, Han, Ji-Youn, Lee, Ki Hyeong, Kim, Sang-We, Kim, Dong-Wan, Lee, Yun-Gyoo, Cho, Eun Kyung, Kim, Joo-Hang, Lee, Gyeong-Won, Lee, Jong-Seok, Min, Young Joo, Kim, Jin-Soo, Lee, Sung Sook, Kim, Hye Ryun, Hong, Min Hee, Ahn, Jin Seok, Sun, Jong-Mu, Kim, Heung Tae, Lee, Dae Ho, Kim, Sohee, Cho, Byoung Chul.

Call Numbers:

Record Identifier: TN_cdi_proquest_journals_2320923108

Language: English

Formats: Articles

Publishers: England: Elsevier Ltd

Permalink: https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2320923108

Articles

Articles

Export this record

Export selected records

  • Export to excel
  • Permalink

    • Export record to excel

    File type to download

    Beta version

    Record title

    Lazertinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: results from the dose escalation and dose expansion parts of a first-in-human, open-label, multicentre, phase 1–2 study

    Record identifier

    TN_cdi_proquest_journals_2320923108

    Record permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2320923108

    Share

    Lazertinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: results from the dose escalation and dose expansion parts of a first-in-human, open-label, multicentre, phase 1–2 study

    ACCESS
    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2320923108

    Lazertinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: results from the dose escalation and dose expansion parts of a first-in-human, open-label, multicentre, phase 1–2 study

    Full title

    Lazertinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: results from the dose escalation and dose expansion parts of a first-in-human, open-label, multicentre, phase 1–2 study

    Author / Creator

    Ahn, Myung-Ju ; Han, Ji-Youn ; Lee, Ki Hyeong ; Kim, Sang-We ; Kim, Dong-Wan ; Lee, Yun-Gyoo ; Cho, Eun Kyung ; Kim, Joo-Hang ; Lee, Gyeong-Won ; Lee, Jong-Seok ; Min, Young Joo ; Kim, Jin-Soo ; Lee, Sung Sook ; Kim, Hye Ryun ; Hong, Min Hee ; Ahn, Jin Seok ; Sun, Jong-Mu ; Kim, Heung Tae ; Lee, Dae Ho ; Kim, Sohee ; Cho, Byoung Chul

    Publisher

    England: Elsevier Ltd

    Journal title

    The lancet oncology, 2019, Vol.20 (12), p.1681-1690

    Record Identifier

    TN_cdi_proquest_journals_2320923108

    Language

    English

    Formats

    Articles

    Publication information

    Publisher

    Subjects

    Subjects and topics

    Acne Cancer therapies Care and treatment Drug dosages Epidermal growth factor receptors Lung cancer Lung cancer, Non-small cell Metastasis Mutation Non-small cell lung carcinoma Oncology Patients Pharmacokinetics Protein-tyrosine kinase Pruritus Radiation therapy Safety Small cell lung carcinoma Solid tumors Studies Tumors

    More information

    — SCOPE AND CONTENTS

    Contents

    — ALTERNATIVE TITLES

    Full title

    — AUTHORS, ARTISTS AND CONTRIBUTORS

    Author / Creator

    Identifiers

    — PRIMARY IDENTIFIERS

    Record Identifier

    TN_cdi_proquest_journals_2320923108

    Permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2320923108

    — OTHER IDENTIFIERS

    ISSN

    E-ISSN

    DOI

    How to access this item

    Online

    1 item

    How to access?

    Login with a Library card

    Full text available >

    About resource >

    View in old catalogue

    Connecting people and collections